Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Adrenaline |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine + inotropics |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine [cardiovascular use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline 1:1000 1mg/1mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline 1:10,000 1mg/10mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline 1000micrograms/mL injection solution 0.3mL prefilled pen (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline 150micrograms/0.3mL preloaded injection pen (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline 1:1000 5mg/5mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline 100micrograms/mL injection solution 10mL prefilled syringe (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline 1mg/mL injection solution 1mL prefilled syringe (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline 1:1000 5mg/5mL prefilled syringe (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine [resp] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline 0.5% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline 10 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine 1:1000 1mg/mL topical solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline acid tartrate 0.01% preservative-free eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline acid tartrate 0.1% preservative-free eye drops (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neutral epinephrine 0.05% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neutral adrenaline 0.1% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neutral epinephrine 0.25% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neutral epinephrine 0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline 1:10,000 300micrograms/3mL prefilled syringe (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Parenteral adrenaline |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adrenaline eye drops (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine hydrochloride 1% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine hydrochloride 2% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine hydrochloride 1.9mg dental pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine hydrochloride 1.15mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine hydrochloride 0.5mg/in |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine hydrochloride 0.85mg/in |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine hydrochloride 1.15mg/in |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine hydrochloride 0.82mg/in |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine hydrochloride 0.5mg/inch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine 1mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine 0.5mg/mL (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine 1mg/mL injection solution ampoule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine 0.15mg/0.3mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine 2.0% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline 5 mg/mL eye solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine 1.0% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine hydrochloride 0.108mg/cm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine hydrochloride 0.6mg pellets |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine hydrochloride 1.7mg/in |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine hydrochloride 0.182mg/cm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine hydrochloride 0.364mg/cm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine 1mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine hydrochloride 1mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Articaine hydrochloride + epinephrine 40mg/0.01mg injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine + lidocaine hydrochloride 0.01mg/20mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine 20mcg/lidocaine hydrochloride 20mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine + lidocaine hydrochloride 10mcg/10mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine + lidocaine hydrochloride 10mcg/20mg injecti |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine + lidocaine hydrochloride 20mcg/20mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine 5mcg/lidocaine hydrochloride 15mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine bitartrate + lidocaine hydrochloride 0.005mg/10mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine bitartrate + lidocaine hydrochloride 10mcg/20mg inj |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine bitartrate + lidocaine hydrochloride 20mcg/20mg inj |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine bitartrate + pilocarpine hydrochloride 1%/1%wv solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine bitartrate + pilocarpine hydrochloride 1ns/4%wv solution (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine bitartrate + pilocarpine hydrochloride 1ns/6%wv solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine bitartrate + pilocarpine hydrochloride ns/2%wv solution (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Epinephrine bitartrate |
Is a |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline hydrochloride |
Is a |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline acetate |
Is a |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine acid tartrate |
Is a |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental adrenalin poisoning |
Causative agent (attribute) |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional adrenalin poisoning |
Causative agent (attribute) |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenalin poisoning of undetermined intent |
Causative agent (attribute) |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
injection d'adrénaline à visée hémostatique pour une lésion gastrique |
Direct substance |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Injection of epinephrine into lesion of duodenum for hemostasis |
Direct substance |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Zinc sulfate+epinephrine eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lignocaine hydrochloride+adrenaline 0.5%/1:200,000 injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing cocaine and epinephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lidocaine hydrochloride+epinephrine 2%/1:80,000 cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing epinephrine and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cocaine+epinephrine 5%/0.02% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guanethidine monosulfate+adrenaline 3%/0.5% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely epinephrine 2 milligram/1 milliliter and guanethidine monosulfate 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guanethidine monosulfate+epinephrine 1%/0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guanethidine monosulfate+adrenaline 0.5%/0.1% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lignocaine hydrochloride+adrenaline 4% preservative free nasal drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lignocaine hydrochloride+adrenaline 1%/1:200,000 injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lignocaine hydrochloride+adrenaline 2%/1:200,000 injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning caused by epinephrine (disorder) |
Causative agent (attribute) |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Injection of epinephrine (procedure) |
Direct substance |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lidocaine hydrochloride 1.5%/epinephrine 1:200,000 injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lidocaine hydrochloride 2%/epinephrine 1:500,000 injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lidocaine hydrochloride+epinephrine 2%/1:100,000 injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bupivacaine hydrochloride + epinephrine bitartrate 5mg/0.0091mg inject |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Respiratory epinephrine preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lidocaine hydrochloride 1%/epinephrine 1:100,000 injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing epinephrine and fluorouracil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Etidocaine hydrochloride+epinephrine 1.5%/1:200000 injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lidocaine 2%/epinephrine (1:200000) injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Etidocaine hydrochloride+epinephrine 1.5%/1:200000 injection solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lidocaine 1%/epinephrine (1:200000) injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bupivacaine+adrenaline (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Guanethidine monosulfate+epinephrine 0.25%/0.05% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bupivacaine+epinephrine 0.25%/1:200000 sterile wrapped injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenaline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|